Association between mortality rates and medication and residential treatment after inpatient medically managed opioid withdrawal: A cohort analysis
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Association between mortality rates and medication and residential treatment after inpatient medically managed opioid withdrawal: A cohort analysis

Filetype[PDF-1.79 MB]


  • English

  • Details:

    • Alternative Title:
      Addiction
    • Description:
      Background and aim:

      Medically managed opioid withdrawal (detox) can increase the risk of subsequent opioid overdose. We assessed the association between mortality following detox and receipt of medications for opioid use disorder (MOUD) and residential treatment after detox.

      Design:

      Cohort study generated from individually linked public health datasets

      Setting:

      Massachusetts, USA

      Participants:

      30,681 opioid detox patients with 61,819 detox episodes between 2012–2014

      Measurements:

      Treatment categories included no post-detox treatment, MOUD, residential treatment, or both MOUD and residential treatment identified at monthly intervals. We classified treatment exposures in two ways: a) ‘On Treatment’ included any month where a treatment was received, b) ‘With Discontinuation’ individuals were considered exposed through the month following treatment discontinuation. We conducted multivariable Cox proportional hazards analyses and extended Kaplan-Meier estimator cumulative incidence for all-cause and opioid-related mortality for the treatment categories as monthly time varying exposure variables.

      Findings:

      Twelve months after detox, 41% received MOUD for a median of 3 months, 35% received residential treatment for a median of 2 months, and 13% received both for a median of 5 months. In On Treatment analyses for all-cause mortality, compared with no treatment, adjusted hazard ratios (AHR) were 0.33 (95% CI: 0.26–0.43) for MOUD, 0.63 (95% CI: 0.47–0.84) for residential treatment, and 0.11 (95% CI: 0.03–0.42) for both. In With Discontinuation analyses for all-cause mortality, compared with no treatment, AHRs were 0.51 (95% CI: 0.42–0.62) for MOUD, 0.76 (95% CI: 0.59–0.96) for residential treatment, and 0.20 (95% CI:0.08–0.55) for both. Results were similar for opioid-related overdose mortality.

      Conclusions:

      Among people who have undergone medically managed opioid withdrawal, receipt of medications for opioid use disorder (MOUD), residential treatment, or the combination of MOUD and residential treatment were associated with substantially reduced mortality compared with no treatment.

    • Subjects:
    • Pubmed ID:
      32096908
    • Pubmed Central ID:
      PMC7854020
    • Document Type:
    • Collection(s):
    • Main Document Checksum:
    • File Type:

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov